p21-Activated Kinase 4 (PAK4) as a Predictive Marker of Gemcitabine Sensitivity in Pancreatic Cancer Cell Lines
Sung-Ung Moon, Jin Won Kim, Ji Hea Sung, Mi Hyun Kang, Se-Hyun Kim, Hyun Chang, Jeong-Ok Lee, Yu Jung Kim, Keun-Wook Lee, Jee Hyun Kim, Soo-Mee Bang, Jong Seok Lee
Cancer Res Treat. 2015;47(3):501-508. Published online 2014 Nov 24 DOI: https://doi.org/10.4143/crt.2014.054
Citations to this article as recorded by 
Biological role of the PAK4 signaling pathway: A prospective therapeutic target for multivarious cancers
Md. Mozibullah, Md. Junaid
Arabian Journal of Chemistry.2023; 16(1): 104438. CrossRef
Expression Patterns of PAK4 and PHF8 Are Associated with the Survival of Gallbladder Carcinoma Patients
Ae Ri Ahn, Maryam Karamikheirabad, Min Su Park, Junyue Zhang, Hyun Sun Kim, Ji Su Jeong, Kyoung Min Kim, Ho Sung Park, Kyu Yun Jang
Diagnostics.2023; 13(6): 1149. CrossRef
PAK4 inhibition significantly potentiates Gemcitabine activity in PDAC cells via inhibition of Wnt/β-catenin, p-ERK/MAPK and p-AKT/PI3K pathways
Charudatt Samant, Ramesh Kale, Anand Bokare, Mahip Verma, K. Sreedhara Ranganath Pai, Mandar Bhonde
Biochemistry and Biophysics Reports.2023; 35: 101544. CrossRef
A novel PAK4 inhibitor suppresses pancreatic cancer growth and enhances the inhibitory effect of gemcitabine
Hong He, Chelsea Dumesny, Ching-Seng Ang, Li Dong, Yi Ma, Jun Zeng, Mehrdad Nikfarjam
Translational Oncology.2022; 16: 101329. CrossRef
Synthesis and biological evaluation of 7H-pyrrolo [2,3-d] pyrimidine derivatives as potential p21-activated kinase 4 (PAK4) inhibitors
Cong Wang, Jiawei Xia, Yan Lei, Rui Lu, Mingliang Zhang, He Lv, Qianqian Hong, Tao Lu, Yadong Chen, Hongmei Li
Bioorganic & Medicinal Chemistry.2022; 60: 116700. CrossRef
A Study on the Effect of the Substituent against PAK4 Inhibition Using In Silico Methods
Hye Ree Yoon, Chong Chul Chai, Cheol Hee Kim, Nam Sook Kang
International Journal of Molecular Sciences.2022; 23(6): 3337. CrossRef
Alloferon Affects the Chemosensitivity of Pancreatic Cancer by Regulating the Expression of SLC6A14
Hyejung Jo, Dahae Lee, Cheolhyeon Go, Yoojin Jang, Suhyun Bae, Tomoyo Agura, Jiye Hong, Dongmin Kang, Yejin Kim, Jae Seung Kang
Biomedicines.2022; 10(5): 1113. CrossRef
The significance of PAK4 in signaling and clinicopathology: A review
Xinbo Yu, Changwei Huang, Jiyuan Liu, Xinyu Shi, Xiaodong Li
Open Life Sciences.2022; 17(1): 586. CrossRef
The trilogy of P21 activated kinase, autophagy and immune evasion in pancreatic ductal adenocarcinoma
Yi Ma, Mehrdad Nikfarjam, Hong He
Cancer Letters.2022; 548: 215868. CrossRef
p21-Activated Kinase: Role in Gastrointestinal Cancer and Beyond
Xiaodong Li, Feng Li
Cancers.2022; 14(19): 4736. CrossRef
Exosome-mediated RNAi of PAK4 prolongs survival of pancreatic cancer mouse model after loco-regional treatment
Lizhou Xu, Farid N. Faruqu, Yau M. Lim, Kee Y. Lim, Revadee Liam-Or, Adam A. Walters, Paul Lavender, David Fear, Claire M. Wells, Julie Tzu-Wen Wang, Khuloud T. Al-Jamal
Biomaterials.2021; 264: 120369. CrossRef
RETRACTED ARTICLE: Long noncoding RNA LINC00657 enhances the malignancy of pancreatic ductal adenocarcinoma by acting as a competing endogenous RNA on microRNA-433 to increase PAK4 expression
Shasha Bi, Yan Wang, Hu Feng, Qingchang Li
Cell Cycle.2020; 19(7): 801. CrossRef
p21-Activated Kinases in Thyroid Cancer
Luis Bautista, Christina M Knippler, Matthew D Ringel
Endocrinology.2020;[Epub] CrossRef
Coordinated dysregulation of cancer progression by the HER family and p21-activated kinases
Rakesh Kumar, Aswathy Mary Paul, Ravikumar Amjesh, Bijesh George, M. Radhakrishna Pillai
Cancer and Metastasis Reviews.2020; 39(3): 583. CrossRef
Antitumor effects of all-trans retinoic acid and its synergism with gemcitabine are associated with downregulation of p21-activated kinases in pancreatic cancer
Kai Wang, Graham S. Baldwin, Mehrdad Nikfarjam, Hong He
American Journal of Physiology-Gastrointestinal and Liver Physiology.2019; 316(5): G632. CrossRef
PAK4 pathway as a potential therapeutic target in pancreatic cancer
Kiruthikah Thillai, Debashis Sarker, Claire Wells
Future Oncology.2018; 14(7): 579. CrossRef
p21-activated kinase signalling in pancreatic cancer: New insights into tumour biology and immune modulation
Kai Wang, Graham S Baldwin, Mehrdad Nikfarjam, Hong He
World Journal of Gastroenterology.2018; 24(33): 3709. CrossRef
Structure, biochemistry, and biology of PAK kinases
Rakesh Kumar, Rahul Sanawar, Xiaodong Li, Feng Li
Gene.2017; 605: 20. CrossRef
Prognostic value of p21‐activated kinase 4 in resected pancreatic cancer
Sehhoon Park, Jin Won Kim, Haeryoung Kim, Ji‐Won Kim, Yu Jung Kim, Keun‐Wook Lee, Jee Hyun Kim, Jai Hwan Kim, Jin‐Hyeok Hwang, Young Rok Choi, Jai Young Cho, Yoo‐Seok Yoon, Ho‐Seong Han
APMIS.2017; 125(8): 699. CrossRef
Pdx1-Cre-driven conditional gene depletion suggests PAK4 as dispensable for mouse pancreas development
Miao Zhao, Parisa Rabieifar, Tânia D. F. Costa, Ting Zhuang, Audrey Minden, Matthias Löhr, Rainer Heuchel, Staffan Strömblad
Scientific Reports.2017;[Epub] CrossRef
Inhibition of p21 activated kinase enhances tumour immune response and sensitizes pancreatic cancer to gemcitabine
Kai Wang, Nhi Huynh, Xiao Wang, Graham Baldwin, Mehrdad Nikfarjam, Hong He
International Journal of Oncology.2017;[Epub] CrossRef
S-1 plus nab
-paclitaxel is a promising regimen for pancreatic cancer in a preclinical model
Masaya Suenaga, Suguru Yamada, Tsutomu Fujii, Chie Tanaka, Mitsuro Kanda, Goro Nakayama, Hiroyuki Sugimoto, Masahiko Koike, Michitaka Fujiwara, Yasuhiro Kodera
Journal of Surgical Oncology.2016; 113(4): 413. CrossRef
FRAX597, a PAK1 inhibitor, synergistically reduces pancreatic cancer growth when combined with gemcitabine
Dannel Yeo, Hong He, Oneel Patel, Andrew M. Lowy, Graham S. Baldwin, Mehrdad Nikfarjam
BMC Cancer.2016;[Epub] CrossRef
PAK4 confers the malignance of cervical cancers and contributes to the cisplatin-resistance in cervical cancer cells via PI3K/AKT pathway
Xiang-Rong Shu, Jing Wu, He Sun, Li-Qun Chi, Jin-Huan Wang
Diagnostic Pathology.2015;[Epub] CrossRef